Neuralink is going to take part in a clinical trial to explore how a device using AI could help people see.

Xpanceo raised a $250 million funding round, which elevates its valuation to $1.35 billion, as it pioneers smart contact ...

CEO Elon Musk, has joined a clinical trial aimed at restoring vision with full or partial blindness through visual prostheses, commonly known as bionic eyes. According to an update posted on the ...

Elon Musk’s brain implant company Neuralink Corp. is collaborating with researchers in California and Spain on a clinical ...